March 2023Association between post-treatment alpha-fetoprotein reduction and outcomes in real-world US patients with advanced hepatocellular carcinomaClinical developmentLiver cancer
February 2023Exposure to US cancer drugs with lack of confirmed benefit after US Food and Drug Administration accelerated approvalUnmet needBreast cancerLung cancerReal-World DataGastric cancerLiver cancer
January 2021Association between post-treatment alpha-fetoprotein (AFP) reduction and outcomes in real-world US patients with advanced hepatocellular carcinomaLiver cancerTreatment and Testing patterns